To hear about similar clinical trials, please enter your email below
Trial Title:
Clinical Evaluation of the Scopio Cell Morphology Technology
NCT ID:
NCT06574308
Condition:
Blood Cancer
Conditions: Official terms:
Hematologic Neoplasms
Study type:
Observational
Overall status:
Not yet recruiting
Study design:
Time perspective:
Cross-Sectional
Intervention:
Intervention type:
Diagnostic Test
Intervention name:
Blood cells classification
Description:
Comparison of the classification of peripheral blood and bone marrow cells with optical
microscope reading with pre-classification using Scopio technology (AI based)
Summary:
Digital morphology is currently expanding and developing new applications based on
artificial intelligence software. We recently published a study comparing screen
validation and microscopic reading of bone marrow aspirates. The aim of the current
research will be the comparison between optical microscope reading and automatic
pre-classification (AI based)
Criteria for eligibility:
Study pop:
Pazienti affetti da emopatie
Sampling method:
Probability Sample
Criteria:
Inclusion Criteria:
- Patients suffering from hemopathies with bone marrow aspirate assessable under the
optical microscope
Exclusion Criteria:
- Patients not affected by blood disorders
- Patients suffering from hemopathies with bone marrow aspirate that cannot be
assessed under the optical microscope
Gender:
All
Minimum age:
18 Years
Maximum age:
80 Years
Healthy volunteers:
No
Locations:
Facility:
Name:
Fondazione Policlinico Universitario A. Gemelli IRCCS
Address:
City:
Roma
Zip:
00168
Country:
Italy
Start date:
September 1, 2024
Completion date:
September 1, 2025
Lead sponsor:
Agency:
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Agency class:
Other
Source:
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT06574308
